K Pharma (TSE:4896) Other Financing: 円0.00 Mil (TTM As of Dec. 2025)


TSE:4896 K Pharma Inc TSE:4896
11 GF Score
Price 円729.00
! 1 Warning Sign
View Full Analysis

What is K Pharma Other Financing?

K Pharma TSE:4896 +4.29% 11 Other Financing is 円0.00 Mil as of Dec. 2025. GuruFocus rates TSE:4896 with a GF Score™ of 11/100. The stock has 1 warning sign investors should review.

K Pharma's Other Financing for the three months ended in Dec. 2025 was 円0.00 Mil.

K Pharma's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was 円0.00 Mil.

K Pharma Other Financing Historical Data

* Premium members only.

The historical data trend for K Pharma's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

K Pharma Other Financing Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
0.00 -0.09 -10.09 0.00 0.00

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4896
11GF Score
K Pharma Inc TSE:4896
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

K Pharma Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of 円0.00 Mil mean?
K Pharma (TSE:4896) has a Other Financing of 円0.00 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for K Pharma and its competitors.
Is K Pharma's Other Financing too high?
K Pharma's current Other Financing is 円0.00 Mil. Overall, K Pharma has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does K Pharma's Other Financing compare to VRTX and REGN?
K Pharma's Other Financing of 円0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for K Pharma and its competitors. K Pharma's current Other Financing is 円0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is K Pharma stock overvalued right now?
K Pharma (TSE:4896) has a current Other Financing of 円0.00 Mil. The current Other Financing is 円0.00 Mil. K Pharma's overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For K Pharma (TSE:4896), the current Other Financing is 円0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

K Pharma Business Description

Address 7-7-7 Roppongi, Tri-Seven Roppongi 8th Floor, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales, and marketing of pharmaceutical products and regenerative medicine products. It is involved in the study of iPs cells in regenerative medicine to treat neurological conditions such as cerebral infarction and SCI.
11GF Score

Get the complete analysis for TSE:4896

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円729.00
Price